Abstract
BackgroundWith standard therapy, which includes chemotherapy and aggressive surgical debulking, relative 5-year survival for newly diagnosed advanced epithelial ovarian cancer is only 30%. AV-OVA-1 is a personal vaccine consisting of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have